Latest News

2019 SMA Researcher Meeting Summary: Basic Research Podium Presentations

August 26, 2019
Posted in , ,

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 attendees join together in Anaheim, […]

Read More ›

Cure SMA to Host August 28th Webinar on Zolgensma Updates

August 23, 2019
Posted in

On Wednesday, August 28th, at 12pm CST (10am PST/11 am MST/1pm EST) Cure SMA will host a webinar to provide updates on Zolgensma. The webinar will be divided into three […]

Read More ›

Thank You for a Wonderful 2019 Annual SMA Conference!

August 15, 2019
Posted in ,

Thank you to everyone who attended the 2019 Annual SMA Conference at the Disneyland in Anaheim, California! It was an impactful weekend of community, research and fun. We are happy […]

Read More ›

Cure SMA Awards Grants to Four States to Expediate the Implementation of SMA Newborn Screening

August 13, 2019
Posted in , ,

On July 3, 2018, Health and Human Services Secretary Alex Azar approved the recommendation that newborn screening for spinal muscular atrophy be implemented nationwide. This recommendation was issued on February 8, 2018, […]

Read More ›

2019 SMA Researcher Meeting Summary: Special Session on Spinal and Neuromuscular Circuitry: Exploring Defects in SMA and Potential Therapeutic Targets

August 12, 2019
Posted in , ,

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 attendees join together in Anaheim, […]

Read More ›

Cure SMA Update on Data Accuracy Issues with AveXis’ SMA Therapy, Zolgensma

August 9, 2019
Posted in

Earlier this week, the FDA issued a statement identifying data accuracy issues with AveXis’ SMA therapy, Zolgensma. Cure SMA immediately opened an investigation into the matter and is committed to […]

Read More ›
Scroll to Top